BioVision Off

Journées de l'Économie (lecture)

March 26^th from 17:00 to 19:00

Lecture given by Esther Duflo in french. "Repenser la lutte contre la pauvreté" au palais de la mutualité.

Université Lyon - CCSTI (Public Conference in French Registration needed)

March 26^th from 18:00 to 20:00 » Amphithèâtre Descartes - Ecole Normale Supérieure (ENS)

"Recherche avancée en médecine, quelles sont les limites?"

Moderator: Michel alberganti (journalist -france culture)

Speakers:

• Miroslav Radman Professor Université Paris Descartes Institut National de la Santé Et de la Recherche Médicale (Inserm) 
• Jean-Claude Ameisen Doctor and Professor of immunology President of ethics committee Institut National de la Santé Et de la Recherche Médicale (Inserm) Member The national consultative ethics committee 
• François Berger Neuro-oncologue au CHU de Grenoble - Professeur, Université Joseph Fourier, Responsable de l’Equipe « Nanomédecine et Cerveau », GIN. 

Click here to see the map || Click here to register || Click here to download the flyer

Cancéropôle CLARA (Scientific Forum)

March 28^th to March 29^th

These two days of conferences and debates are planned to demonstrate progress in Oncology around CLARA's four key themes: Oncology Research in 2020, Research on lymphomas and its perspectives in particular thanks to the European Lymphoma Institute, Recent biological discoveries in Oncology, Open Innovation. New feature in this edition: Five prizes will reward the best abstracts and posters Click here for more information.

Neurodis (workshop)

March 28^th from 9:00 to 11:00

"Invisible to the human eye: extracting more information from brain images"

Traditionally, the appeal of imaging has been its ability to “look inside” the body, and image analysis has been mainly visual. With the advent of standardized coordinate systems, atlas databases, and cheap computing power, it has become possible to probe images beyond what is visible to the naked eye. In this workshop, renowned international experts will describe developments and applications, and discuss implications for neuroscience and clinical care.

Chair / moderation:

• Rolf A Heckemann, MD, PhD, Lyon, France RAH

• Richard SJ Frackowiak, MD, DSc, Lausanne, Switzerland
• Alexander Hammers, MD, PhD, Lyon, France / London,
• Jérémie Mattout, PhD, Lyon, France
• John C Mazziotta, MD, PhD, FAAN, Los Angeles, USA

IMI Education and Training (Workshop)

March 28^th from 9:00 to 10:30

"Innovative Medicines Initiative: E&T Programmes" - Click here to download the brochure

The Innovative Medicines Initiative (IMI) is a unique and large-scale public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA). It is the first Joint Undertaking where the European pharmaceutical industries collectively collaborate with European universities in both research, and education and training.

Programme

• Overall presentation of IMI Education and Training (Speaker Michel Goldman - IMI executive director)
• EMTRAIN (Speaker: Mike Hardman)
• Eu2P (Speaker: Annie Fourier-Reglat)
• Pharmatrain (Speaker: Susanne Daniel)
• Safe SciMet (Speaker: Hans Linden)

Click here for more information

ECRIN (Stakeholder's meeting 2011)
European Clinical Research Infrastructures Network

March 28^th from 11:45 to 13:15

Making Europe a single area for clinical research : the European Clinical Research Infrastructures Network (ECRIN)

Addressing the health grand challenges requires efficient and high-quality clinical research infrastructures to develop innovative medicines, and to optimise treatment and healthcare strategies. The ECRIN experience, leading to defragmentation and to the use of common standards, tools and procedures for multinational trials, will illustrate the integration of the clinical research capacity, providing access to patients and to clinical expertise across Europe. 

Programme:

Chair:

• Investigator-driven clinical trials in Europe by Liselotte Hoejgaard, ESF, EMRC 

Speakers: 

• EU research agenda by Paul Rübig, MEP, STOA
• Europe’s research capacity by Jean-Emmanuel Faure, EU Commission, DG Research and Innovation
• Health and health research challenges in Europe by Silvio Garattini, Mario Negri Institute, ECRIN Scientific Board 
• Addressing these challenges by creating a single area for Clinical research by Jacques Demotes, INSERM, ECRIN coordinator

Click Here for more information

ERINHA (workshop)
"Building of a pan european BSL4 research infrastructure"

March 28^th from 11:45 to 13:15

ERINHA is a project of building a pan-European research infrastructure aiming to reinforce the European coordination and capacities for the study and the surveillance of highly pathogenic micro-organisms. The ERINHA infrastructure will provide open access to state-of-the-art BSL4 facilities for the European scientific community to enhance basic and finalised research activities and diagnostic activities. The infrastructure will promote the harmonization of biosafety and biosecurity procedures will develop standards for the management of biological resources, diagnosis of group 4 pathogens, and training of BSL4 labs users.

ERINHA infrastructure has been included in the roadmap of the European Strategy Forum on Research Infrastructures (ESFRI) in its update of 2008. Formed in 2002, the ESFRI brings together representatives of Member States, Associate Countries and of the Commission. The ESFRI has been commissioned to prepare a roadmap on the long-term needs of research infrastructures in Europe.

ERINHA infrastructure has entered into a preparatory phase of 36 months which has officially started on the 1st November 2010. Its purpose is to bring the ERINHA to the level of legal, financial and organisational maturity required to move to construction and operation phase.

ERINHA preparatory phase is funded by the European Commission under the 7th Framework Programme. The project is coordinated by Inserm at the Jean Mérieux BSL4 laboratory and actually gathers complementary expertise of 22 partners and 13 associated partners from 16 countries across Europe, composed of research institutions including all European BSL4 laboratories, and government bodies.

Euroscience (workshop)
"Nano-Safety – Risk Governance of Manufactured Nanoparticles"

March 28^th from 14:30 to 16:30

On the basis of a report carried out by the European Technology Assessment Group (ETAG) for STOA (Science and Technology Options Assessment) of the European Parliament, the workshop aims to discuss the present state of the potential environmental, health and safety risks of manufactured nanoparticles. Because of the great uncertainties regarding their actual health and environmental effects and numerous methodological challenges to establish risk assessment procedures, risk appraisal and risk management of manufactured particulate nanomaterials are confronted with serious challenges. At the same time precautionary regulatory action is demanded by a number of stakeholders and parts of the general public.

Chair:

• Dr. Raphaela Kitson-Pantano, program director ESOF

Speakers

• Member of STOA of the European Parliament
• Thorsten Fleischer, Institute for Technology Assessment and Systems Analysis-KIT
• M. Laurent LEVY, Professor at Université Joseph Fourier (UFJ)
• Georges Waysand, Euroscience

Symposium : Nutrition for better health 

March 28^th 12h30 to 14h00 (Lunch Symposium)

The BioVision 2011 Lunch Symposium ‘Nutrition for Better Health - Applying New Science with Special Attention to Patient Needs’ is jointly organized by  DSM, Patient Alliances and the International Osteoporosis Foundation. The forum provides a unique platform, where selected experts address and discuss specific nutrition needs and requirements of patients, building on latest progress in science. Besides the relevance of nutrition for patients on a daily basis - be it hospitalized or outdoor patients - and the specific needs responding to various diseases, emerging data will be presented to demonstrate the rapid progress in science and the implications on nutrition. Nutrition is important for human health in all life stages, from conception to the elderly. Moreover, exciting data in the field of vitamin D research and its promising impact on the quality of live for patients will be presented: an excellent case demonstrating the benefits of micronutrients for human health.    

Speakers:
Relevance of nutrition for patients and risk groups
Cees Smit (Professor, IDTM, the Netherlands)

Preparing for life: nutrition, epigenetics and e-health
Régine Steegers-Theunissen (Professor, Erasmus MC, the Netherlands)

Optimal nutrition through the lifecycle
Peter Weber (Scientist, DSM Nutritional Products, Switzerland)

Vitamin D case – Improving quality of life in patients
Heike A. Bischoff-Ferrari (Professor, University Hospital Zurich, Switzerland)

BioVision 2011 Nutrition Summit

March 28^th from 14:45 to 16:30

Open to participants with accreditations only.

The BioVision 2011 Nutrition Summit exclusively unites representatives of patient organizations, health professionals and nutrition experts. 
This meeting provides a unique platform, where the selected committee members jointly address and discuss specific nutrition needs and requirements of patients – building on latest progress in science. 
The resulting statements and recommendations will be leveraging support to health ministries and related bodies worldwide, to engage in and facilitate science-based progress in the field of nutrition and health for patients.

Preparing for Life Initiative

March 28^th from 16:45 to 18:00

“Preparing for Life” is a patient driven initiative originating from the BioVision 2005 plenary session "The beginning of Life".

Its first objective is to contribute to the reduction of maternal and childhood mortality and morbidity, thereby  supporting the Millennium Development Goals of the United Nations.

Every day  30.000 children under age of 5 die and annually 7,9 million children are born with a serious disorder  and all this mainly from preventable causes.

“Preparing for Life” is a joint venture of  groups of patients (IGA), science (academia) and service  (rotary) and open to international organisations, governmental bodies, non-governmental organisations, academics, industry and individuals. 

“Preparing for Life” will promote international and regional awareness of and the development of programmes for preconception care, particularly in middle and low-income countries and so contribute to safe motherhood and the birth of  healthy infants with the expectation of healthy longevity. 

France Biotech (Board meeting)

March 28^th from 17:00 to 19:00

Open to France Biotech Board membres only.
Board Meeting

Vivagora (workshop)

March 28^th from 17:30 to 19:30

Workshop in french. "Le vivant artificiel nous concerne"

La biologie synthétique permet de recréer ou d'inventer les briques du vivant. L'objectif est de réaliser des « bio-raffineries miniatures » pour obtenir des produits pharmaceutiques ou des biocarburants, réparer des tissus, décontaminer des sites pollués,. Avec un marché mondial annoncé de trois milliards en 2016, cette ingénierie d'organismes inédits génère de nombreuses questions sociétales (éthiques), sanitaires et économiques.

• Quels sont les buts poursuivis ? Comment la biologie synthétique transforme-t-elle notre rapport au vivant ?
• Quels sont les risques encourus ? Quels peuvent être les effets sur la biodiversité,?
• Comment se met en place ce biocapital articulant pétrochimie, agro-alimentaire et pharmaceutique ?

Moderator

• Dorothée Benoit Browaeys, déléguée générale de VivAgora

Speakers

• Frédéric Jacquemart, (président d’Inf’OGM)
• François Képès, (Directeur du Programme d’Épigénomique, Genopole, Genavenir 6,Institut de biologie systémique et synthétique (iSSB) )
• Bernadette Bensaude Vincent, (philosophe et historienne de la chimie (Paris Sorbonne) )
• Paul Baduel, (directeur du développement des procédés biotechnologiques, sanofi-aventis)

Click here to download the abstract

Neurodis & Lyon Neuroscience Research Center (Workshop)

March 29^th from 09:00 to 11:00

Research into the mechansims and role of neural synchronization is a key topic in neuroscience today. Seminal studies in animals and humans reveal how the phenomenon of neural synchrony within cell assemblies mediates cognitive processes and how synchronized activity across brain circuits may provide a general mechanism for the coordination of distributed neural activity patterns. Cutting-edge research in this field is also providing critical insight into the pathophysiology of major brain disorders such as Schizophrenia and Autism. Furthermore, the ability to monitor neural synchrony in the high-frequency range is opening up new perspectives for brain-machine interfaces and real-time human electrophysiology. Beyond improving our knowledge of the healthy brain, measuring neural synchrony provides critical insight into brain disorders and future neural rehabilitation techniques.

Chair / moderation:

• Olivier Bertrand, Lyon Neuroscience Research Center, Lyon, France

Speakers:

• Wolf Singer, MD, PhD, Frankfurt, Germany
• Jean-Philippe Lachaux, PhD, Lyon, France
• Emmanuel Procyk, PhD, Lyon, France
• Karim Jerbi, PhD, Lyon, France

France Biotech (Brainstorming meeting)

March 29^th from 09:00 to 12:00

Open to France Biotech Board membres only.
Brainstorming on the future of the industry

Universite de Lyon (Workshop in french)
"LyonTech-la Doua, l'éco-campus démonstrateur et expérimental"

March 29^th from 11:00 to 13:00

L'Université de Lyon propose un workshop sur le projet de l'éco-campus LyonTech-la Doua. Véritable laboratoire à ciel ouvert, ce campus deviendra un support à la recherche, à la formation et à l'expérimentation en matière de gestion de l'eau, de biodiversité en ville, de pollution des sols, de gestion des énergies, d'usage des espaces publics urbains, etc. Trois membres du Comité Scientifique de l'éco-campus et deux représentants du monde industriel apporteront leur vision d'un partenariat entre la recherche académique et les entreprises autour d'un espace de formation et de recherche devenant un lieu de test et de démonstration de technologies innovantes.

France Biotech (Biotech Panorama)

March 29^th from 12:30 to 14:00

The results of this study will be presented on the Lyon Biopole pavilion on Tuesday, March 29^th at 12:30
A Wine & Cheese reception will follow.

This study analyses the life sciences industry every year and is divided in two parts: the first one presents the key figures and major trends in the international scene while the other, including a survey conducted by France Biotech among French companies within the biotech sector - provides detailed information on the financing (venture capital, IPOs, SPOs, alliances, etc.), stakes, trends, initiatives and fields of applications. The study includes numerous graphs and tables describing the situation in France and internationally.

• The current international context of world life sciences
• The evolution of biotech industry in France :
  • employment rates
  • product evolution / forecasts based on the biotech industry
  • technologic advances made by French companies
  • buisness models
• The financial panorama : strategic alliances, fund raisings made by French companies -Public policies in favor of research, innovation and biotechnologies in France